Hypoglycemia levels 1–3
Endocrinology
Also known as: Hypoglykämie-Level 1–3 (ADA/IHSG) · Hipoglisemi seviyeleri 1–3 · Hypoglycaemia levels 1–3 (ADA / International Hypoglycaemia Study Group)
What it is for
Classification of hypoglycaemia in people with diabetes by measured glucose (plasma, capillary or continuous glucose monitoring) and by clinical severity.
Classification
| Category | Description |
|---|---|
| Level 1 | glucose <70 mg/dl (<3.9 mmol/l) and ≥54 mg/dl (≥3.0 mmol/l) (alert value). |
| Level 2 | glucose <54 mg/dl (<3.0 mmol/l): clinically significant hypoglycaemia; neuroglycopenic symptoms begin at about this level. |
| Level 3 | severe event with altered mental and/or physical status needing another person's assistance for recovery, whatever the glucose value. |
Source
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026
ADA · Diabetes Care 2026;49(Suppl 1):S132–S149
DOI: 10.2337/dc26-S006
PMID: 41358894
- Edition
- ADA Standards of Care in Diabetes 2026 (section 6); levels proposed by the International Hypoglycaemia Study Group (IHSG) 2017
- Checked on
Summary of the published classification in our own words. Not a substitute for the original publication.
A question about this classification?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
More classifications: Endocrinology
- Bethesda System for Reporting Thyroid Cytopathology (TBSRTC 2023)
- Clinical Activity Score (Graves' orbitopathy)
- Diabetes diagnostic criteria (ADA 2026)
- DKA diagnostic criteria (2024 consensus)
- Gestational diabetes diagnostic criteria (IADPSG)
- University of Texas wound classification
- Wagner classification (diabetic foot)
- WHO BMI classification